Autism rates reach 1-in-31 as HHS Secretary Kennedy warns of “unprecedented crisis”
- The CDC reports autism now affects 1 in 31 U.S. children by age 8 (up from 1 in 36 in 2020) — a 16% increase — with boys and California showing the highest rates. HHS Secretary Robert F. Kennedy Jr. calls it an “unprecedented epidemic.”
- Kennedy pushes to investigate vaccines as a potential environmental trigger for autism. He vows to identify ASD causes by September 2025 and reform vaccine safety programs like the National Vaccine Injury Compensation Program.
- Scientists, including Dr. Alex Kolevzon, dispute the “epidemic” label, attributing rising rates to broader diagnostic criteria and better detection. They warn that vaccine hesitancy fueled by Kennedy’s stance risks measles outbreaks and public health harm.
- Parent groups (e.g., Health Freedom Ohio) demand transparency from pharmaceutical companies, citing lack of placebo-controlled trials and liability shields. Some share personal stories of post-vaccine regression and promote holistic therapies as alternatives.
A new report from the Centers for Disease Control and Prevention (CDC) shows autism now affects 1 in 31 U.S. children by age 8, marking a 16.1% increase from findings two years earlier. The soaring numbers have prompted a fierce debate over causes, with Health and Human Services Secretary Robert F. Kennedy Jr. calling the rise an “unprecedented epidemic” and framing it as a crisis “a thousand times more threatening than COVID-19.” At the heart of the controversy is Kennedy’s insistence on exploring potential links to vaccines — viewed as heretical by mainstream scientists — and the growing demands from advocacy groups for transparency and systemic reform.
CDC report reveals steep increase in autism prevalence
The CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network survey, published April 15, 2025, found 1 in 31 children born in 2014 are diagnosed with autism spectrum disorder (ASD) by age 8, up from 1 in 36 in 2020. The rise, described as “astounding” by Kennedy, reaches 1 in 20 boys and 1 in 12.5 in California, the highest recorded rate in the U.S. The CDC attributes the surge partly to greater awareness and diagnostic improvements, but Kennedy dismisses this explanation. “Doctors in the past weren’t missing cases,” he stated, accusing authorities of ignoring environmental factors and pharmaceutical influence.
The climb is stark compared to 1992, when ASD prevalence was 1 in 150. By 2000, it was 1 in 150, rising to 1 in 44 by 2018 and 1 in 36 by 2020. Kennedy’s HHS now calls for urgent research into these environmental triggers, including vaccines. “By September, we will know what caused this epidemic, and we’ll eliminate those exposures,” he vowed at a Cabinet meeting earlier this month, pledging to assemble a global team of scientists.
Kennedy’s crusade against vaccine safety paradigms
An outspoken critic of the system, Kennedy has long tied childhood ASD to neurotoxic additives in vaccines, such as aluminum adjuvants. His stance clashes with the scientific consensus, which has repeatedly discredited the vaccine-autism link through multiple studies. Yet his appointment as HHS Secretary — bolstered by President Donald Trump’s directive to investigate ASD origins — has injected urgency into the debate.
Kennedy’s initiatives include revamping the National Institutes of Health to prioritize environmental and genetic ASD research over drug development. “The risks of this crisis are beyond imagine,” he said, citing costs including lost productivity and lifelong care. His team has also launched efforts to reform the 1986 National Vaccine Injury Compensation Program (VICP), which shielded manufacturers from liability, critics argue, discouraging safety transparency.
Skeptics, however, question his approach. Kristyn Roth of the Autism Society of America warned the “@EpochTimesHealth” that Kennedy risks “going backward” by resurrecting “debunked theories.” Experts like Dr. Alex Kolevzon, director of Mount Sinai’s Seaver Autism Center, counter that “vaccines do not cause autism” and dispute the “epidemic” framing, noting the rise reflects better detection rather than a true increase in cases.
Advocates push for transparency amid rising parental concerns
Parent advocates, meanwhile, argue the system has failed families like Noah’s mother, who recounted her son’s regression after an MMR vaccine injury. Her journey inspired an autism-focused conference and a nonprofit offering holistic healing solutions, emphasizing diet and environmental detox.
Groups such as Health Freedom Ohio and Mississippi Parents for Vaccine Rights are demanding rigorous safety studies and accountability for pharmaceutical companies. “There’s no liability for Big Pharma,” said Ms. Perry of the latter group, citing the lack of placebo-controlled vaccine trials. Parents like Scott Shoemaker, president of Health Freedom Ohio, insist the U.S. has “failed the most vulnerable” through vaccine mandates and corporate influence.
Technological tools are also emerging to bridge gaps in research. A planned open-source AI model, focusing on links between ASD and toxins, aims to aggregate studies acknowledging the vaccine-autism connection — a departure from mainstream models.
Scientific community contests the “epidemic” label
The belief that environmental exposures like vaccines drive ASD clashes with scientific consensus that genetics plays the largest role. Dr. Kolevzon noted the rise partly reflects evolving diagnostic criteria, and he stressed the dangers of vaccine hesitancy driven by misinformation. “We’re seeing measles cases again because of this,” he said.
The CDC’s report also found ASD prevalence higher among Black and Hispanic children than white peers — a disparity attributed to improved access to services. However, Kennedy and advocates argue it signals deeper inequities in environmental toxin exposure, which the HHS plans to investigate.
The road ahead – navigating science and advocacy in the ASD debate
As Kennedy’s September 2025 deadline looms, the ASD issue tests America’s trust in both science and activism. For families like Noah’s, the fight is personal: “The truth will win,” his mother said. Scientists caution, however, that deviating from evidence-based findings risks public health consequences.
The outcome could redefine vaccination protocols, public health governance and support for ASD communities. Whether Kennedy’s team uncovers a “Big Pharma” conspiracy or confirms the complexity of genetics and environment remains uncertain. One truth is clear: The stakes for America’s children — and its faith in science — are enormous.
Sources include: